Holista Revenue Edges Higher, But Collie Plant Start Delayed Until 2027
HCT: $0.033 -10.81% · MC: $12M
Holista Colltech reported quarterly revenue of approximately $2 million, up 5% from the previous quarter, while customer receipts rose 12%; operating cash flow was positive after excluding the final ProImmune settlement payment, but reported cash outflow remained substantial. The company had approximately $1 million in available funding at quarter-end and said Collie facility operations are now targeted to begin between May and July 2027, later than previously planned due to additional approval requirements.

Comments